RGEN : Repligen stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-03-23 |
|---|---|---|---|---|
| 2023 | $127.46 | $95.93 | $158.39 | -21.63% |
| 2024 | $64.12 | $43.65 | $89.63 | -60.57% |
| 2025 | $57.07 | $38.91 | $103.63 | -64.91% |
| 2026 | $92.69 | $69.23 | $113.74 | -43.01% |
| 2027 | $114.06 | $75.83 | $141.96 | -29.87% |
| 2028 | $88.04 | $69.28 | $129.74 | -45.87% |
| 2029 | $72.55 | $63.38 | $87.6 | -55.39% |
| 2030 | $83.36 | $70.54 | $89.68 | -48.74% |
| 2031 | $76.17 | $73.2 | $81.9 | -53.17% |
| 2032 | $81.24 | $77.73 | $83.11 | -50.05% |
| 2033 | $75.64 | $74.82 | $76.53 | -53.5% |
The 6 Wall Street analysts offering Repligen stock forecast in the last 6 months have average price target of
$196.67 with a high forecast of $240.0 and a low forecast of $180.0.
The average Repligen stock forecast represents a 20.92%
increase from the last price of $162.639999389648.
From AI system, total return is 2366.52% from 4098 forecasts.
For Repligen stock forecast for 2023, 9 predictions are offered for each month of 2023 with average Repligen stock
forecast of $127.46, a high forecast of $158.39, and a low forecast of $95.93.
The average Repligen stock forecast 2023 represents a -21.63%
decrease from the last price of $162.639999389648.
For Repligen stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Repligen stock
forecast of $64.12, a high forecast of $89.63, and a low forecast of $43.65.
The average Repligen stock forecast 2024 represents a -60.57%
decrease from the last price of $162.639999389648.
For Repligen stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Repligen stock
forecast of $92.69, a high forecast of $113.74, and a low forecast of $69.23.
The average Repligen stock forecast 2026 represents a -43.01%
decrease from the last price of $162.639999389648.
For Repligen stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Repligen stock
forecast of $88.04, a high forecast of $129.74, and a low forecast of $69.28.
The average Repligen stock forecast 2028 represents a -45.87%
decrease from the last price of $162.639999389648.
For Repligen stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Repligen stock
forecast of $76.17, a high forecast of $81.9, and a low forecast of $73.2.
The average Repligen stock forecast 2031 represents a -53.17%
decrease from the last price of $162.639999389648.
For Repligen stock forecast for 2033 (10 year), 3 predictions are offered for each month of 2033 with average Repligen stock
forecast of $75.64, a high forecast of $76.53, and a low forecast of $74.82.
The average Repligen stock forecast 2033 represents a -53.5%
decrease from the last price of $162.639999389648.
Please, see more forecasts below.
RGEN : Repligen stock forecast by Wall Street Analysts
The average Repligen stock forecast from last 6 month is $196.67, and this show a -10.2% decrease in average from the prior price target of the each prediction. Also, this average forecast of $196.67 represents a -19.34% decrease from the past average forecast of $243.83, 6 months ago from 6 wall street analysts.
Repligen stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-03-27 | $158.14 | -2.77% |
| 2023-03-28 | $161.64 | 2.21% |
| 2023-03-29 | $160.79 | -0.52% |
| 2023-03-30 | $160.44 | -0.22% |
| 2023-03-31 | $158.37 | -1.30% |
RGEN : Long term Repligen stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Apr. is $158.39 , for 2024 Mar. is $78.60 , for 2027 Mar. is $89.79 , for 2028 Mar. is $98.43 , for 2032 Mar. is $81.72 , and for 2033 Mar. is $74.82.
RGEN : Repligen stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Apr. | $158.39 | -2.61% |
| 2023 May. | $152.11 | -3.97% |
| 2023 Jun. | $145.12 | -4.59% |
| 2023 Jul. | $137.35 | -5.35% |
| 2023 Aug. | $127.57 | -7.12% |
| 2023 Sep. | $118.08 | -7.44% |
| 2023 Oct. | $109.86 | -6.96% |
| 2023 Nov. | $102.69 | -6.53% |
| 2023 Dec. | $95.93 | -6.58% |
RGEN : Repligen stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $89.63 | -6.57% |
| 2024 Feb. | $83.82 | -6.48% |
| 2024 Mar. | $78.60 | -6.22% |
| 2024 Apr. | $73.74 | -6.19% |
| 2024 May. | $69.15 | -6.23% |
| 2024 Jun. | $64.79 | -6.30% |
| 2024 Jul. | $60.66 | -6.37% |
| 2024 Aug. | $56.71 | -6.52% |
| 2024 Sep. | $52.95 | -6.63% |
| 2024 Oct. | $49.46 | -6.61% |
| 2024 Nov. | $46.31 | -6.36% |
| 2024 Dec. | $43.65 | -5.74% |
RGEN : Repligen stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $41.54 | -4.84% |
| 2025 Feb. | $39.96 | -3.80% |
| 2025 Mar. | $39.04 | -2.32% |
| 2025 Apr. | $38.91 | -0.32% |
| 2025 May. | $39.76 | 2.18% |
| 2025 Jun. | $42.53 | 6.97% |
| 2025 Jul. | $47.58 | 11.89% |
| 2025 Aug. | $55.08 | 15.76% |
| 2025 Sep. | $65.77 | 19.41% |
| 2025 Oct. | $78.62 | 19.53% |
| 2025 Nov. | $92.37 | 17.48% |
| 2025 Dec. | $103.63 | 12.19% |
RGEN : Repligen stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $110.76 | 6.89% |
| 2026 Feb. | $113.74 | 2.68% |
| 2026 Mar. | $113.15 | -0.51% |
| 2026 Apr. | $109.87 | -2.90% |
| 2026 May. | $104.78 | -4.63% |
| 2026 Jun. | $98.27 | -6.21% |
| 2026 Jul. | $90.89 | -7.51% |
| 2026 Aug. | $83.25 | -8.41% |
| 2026 Sep. | $76.16 | -8.51% |
| 2026 Oct. | $71.12 | -6.61% |
| 2026 Nov. | $69.23 | -2.66% |
| 2026 Dec. | $71.08 | 2.67% |
RGEN : Repligen stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $75.83 | 6.68% |
| 2027 Feb. | $82.37 | 8.64% |
| 2027 Mar. | $89.79 | 9.00% |
| 2027 Apr. | $97.43 | 8.52% |
| 2027 May. | $105.10 | 7.87% |
| 2027 Jun. | $112.82 | 7.34% |
| 2027 Jul. | $120.62 | 6.92% |
| 2027 Aug. | $128.37 | 6.42% |
| 2027 Sep. | $135.36 | 5.45% |
| 2027 Oct. | $140.42 | 3.74% |
| 2027 Nov. | $141.96 | 1.10% |
| 2027 Dec. | $138.65 | -2.33% |
RGEN : Repligen stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $129.74 | -6.43% |
| 2028 Feb. | $115.57 | -10.92% |
| 2028 Mar. | $98.43 | -14.83% |
| 2028 Apr. | $82.62 | -16.06% |
| 2028 May. | $72.45 | -12.32% |
| 2028 Jun. | $69.28 | -4.37% |
| 2028 Jul. | $71.46 | 3.13% |
| 2028 Aug. | $76.08 | 6.46% |
| 2028 Sep. | $80.89 | 6.33% |
| 2028 Oct. | $84.73 | 4.75% |
| 2028 Nov. | $87.13 | 2.84% |
| 2028 Dec. | $88.07 | 1.08% |
RGEN : Repligen stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $87.60 | -0.54% |
| 2029 Feb. | $85.81 | -2.04% |
| 2029 Mar. | $82.86 | -3.44% |
| 2029 Apr. | $78.92 | -4.75% |
| 2029 May. | $74.36 | -5.78% |
| 2029 Jun. | $69.84 | -6.07% |
| 2029 Jul. | $66.18 | -5.23% |
| 2029 Aug. | $63.99 | -3.32% |
| 2029 Sep. | $63.38 | -0.95% |
| 2029 Oct. | $64.09 | 1.12% |
| 2029 Nov. | $65.71 | 2.53% |
| 2029 Dec. | $67.91 | 3.36% |
RGEN : Repligen stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $70.54 | 3.86% |
| 2030 Feb. | $73.55 | 4.27% |
| 2030 Mar. | $76.95 | 4.62% |
| 2030 Apr. | $80.55 | 4.69% |
| 2030 May. | $83.84 | 4.08% |
| 2030 Jun. | $86.53 | 3.21% |
| 2030 Jul. | $88.52 | 2.30% |
| 2030 Aug. | $89.62 | 1.24% |
| 2030 Sep. | $89.68 | 0.07% |
| 2030 Oct. | $88.78 | -1.00% |
| 2030 Nov. | $87.08 | -1.92% |
| 2030 Dec. | $84.71 | -2.72% |
RGEN : Repligen stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $81.90 | -3.32% |
| 2031 Feb. | $79.01 | -3.52% |
| 2031 Mar. | $76.46 | -3.22% |
| 2031 Apr. | $74.57 | -2.47% |
| 2031 May. | $73.50 | -1.45% |
| 2031 Jun. | $73.20 | -0.41% |
| 2031 Jul. | $73.53 | 0.45% |
| 2031 Aug. | $74.27 | 1.01% |
| 2031 Sep. | $75.24 | 1.31% |
| 2031 Oct. | $76.32 | 1.43% |
| 2031 Nov. | $77.44 | 1.47% |
| 2031 Dec. | $78.58 | 1.48% |
RGEN : Repligen stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $79.73 | 1.45% |
| 2032 Feb. | $80.80 | 1.34% |
| 2032 Mar. | $81.72 | 1.14% |
| 2032 Apr. | $82.44 | 0.88% |
| 2032 May. | $82.91 | 0.58% |
| 2032 Jun. | $83.11 | 0.23% |
| 2032 Jul. | $82.96 | -0.17% |
| 2032 Aug. | $82.46 | -0.61% |
| 2032 Sep. | $81.59 | -1.06% |
| 2032 Oct. | $80.42 | -1.43% |
| 2032 Nov. | $79.08 | -1.66% |
| 2032 Dec. | $77.73 | -1.70% |
RGEN : Repligen stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $76.53 | -1.55% |
| 2033 Feb. | $75.55 | -1.27% |
| 2033 Mar. | $74.82 | -0.97% |
Frequently Asked Questions about Repligen stock forecast
Is Repligen a good long term stock?
From Repligen stock forecast , Repligen (RGEN) stock cannot be a good investment choice. According to Tudal, the Repligen stock price forecast for 2023 Apr. is $158.390408668875 From Repligen stock forecast , Repligen (RGEN) stock cannot be a good investment choice. According to Tudal, the Repligen stock price forecast for 2024 Mar. is $78.6042134623456 From Repligen stock forecast , Repligen (RGEN) stock cannot be a good investment choice. According to Tudal, the Repligen stock price forecast for 2027 Mar. is $89.7862492295671 From Repligen stock forecast , Repligen (RGEN) stock cannot be a good investment choice. According to Tudal, the Repligen stock price forecast for 2028 Mar. is $98.4296672211874 From Repligen stock forecast , Repligen (RGEN) stock cannot be a good investment choice. According to Tudal, the Repligen stock price forecast for 2032 Mar. is $81.718885713045 From Repligen stock forecast , Repligen (RGEN) stock cannot be a good investment choice. According to Tudal, the Repligen stock price forecast for 2033 Mar. is $74.8212427192938
Is Repligen stock overvalued?
Repligen (RGEN) stock is expected to go DOWN . Therefore, Tudal would say that Repligen (RGEN) stock is overvalued.
Will Repligen stock price go up?
No. The Repligen stock price forecast for 2024 Mar. is $78.6042134623456
Is Repligen stock a good buy now?
Since closing price on 2023-03-23 is $162.639999389648 and forecast for 2024 Mar. is $78.60, Repligen stock is not a good 1 year investment.